Does NuScale (SMR) Doubling Authorized Shares Hint At Strategic Flexibility Or Future Dilution Pressure?

• NuScale Power Corporation disclosed that shareholders at a special meeting on December 16, 2025 approved an amendment to its Certificate of Incorporation, raising the authorized Class A common shares from 332,000,000 to 662,000,000 to support future financing and corporate needs.
• This shift nearly doubles NuScale’s potential equity issuance capacity, sharpening investor attention on how the company balances funding its capital‑intensive small modular reactor ambitions against dilution risk for existing holders.
• We’ll now examine how this substantial increase in authorized shares could reshape NuScale Power’s investment narrative and future capital-raising path.

We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

NuScale Power Investment Narrative Recap

To own NuScale today, you have to believe that its NRC approved small modular reactor design will translate into firm, long term contracts and eventual commercial plants. The sharp increase in authorized shares mostly affects how NuScale might fund that journey and near term dilution risk, but it does not change the key short term catalyst: converting Romanian and TVA engagements into binding customer commitments.

The most relevant recent development alongside the share authorization is NuScale’s expanded at the market equity program of up to US$750,000,000, which already signaled a heavier reliance on fresh equity capital. Together, ongoing ATM issuance and the larger share pool frame the core trade off for investors between funding an capital intensive build out and the risk that future equity raises arrive before meaningful SMR revenues materialize.

Yet behind the appeal of first mover SMR status and big headline project numbers, investors should also be aware of...

Read the full narrative on NuScale Power (it's free!)

NuScale Power's narrative projects $402.3 million revenue and $42.2 million earnings by 2028.

Uncover how NuScale Power's forecasts yield a $36.58 fair value, a 128% upside to its current price.

Exploring Other Perspectives

Eleven Simply Wall St Community fair value estimates for NuScale span roughly US$1 to US$37, showing how far apart individual views can be. Before taking a side, you may want to weigh that wide dispersion against the very real possibility of further equity dilution if long term customer agreements and cash flows do not firm up as expected.

Explore 11 other fair value estimates on NuScale Power - why the stock might be worth less than half the current price!

Build Your Own NuScale Power Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your NuScale Power research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free NuScale Power research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate NuScale Power's overall financial health at a glance.

No Opportunity In NuScale Power?

Our top stock finds are flying under the radar-for now. Get in early:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com